The Food and Drug Administration has approved a generic version of the abortion pill mifepristone, expanding its supply at a time when the Trump administration is under pressure from abortion opponents to sharply restrict access to abortion pills. The approval, issued on Tuesday without a public announcement, means that three American companies can now produce mifepristone for abortion. The F.D.A. approved the original pill 25 years ago and in 2019 approved the first generic version. The...